US Stock MarketDetailed Quotes

AIMT Aimmune Therapeutics

Watchlist

0.000
0.0000.00%

Close Nov 27 09:30 ET

0Market Cap0.00P/E (TTM)

Aimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

(Q2)Jun 30, 2019

(Q1)Mar 31, 2019

(FY)Dec 31, 2018

(Q4)Dec 31, 2018

(Q3)Sep 30, 2018

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-19.37%-55.11M

-56.70%-71.81M

-15.54%-195.41M

-1.97%-52.56M

-23.24%-50.85M

-26.30%-46.17M

-15.25%-45.83M

-69.80%-169.13M

-61.46%-51.55M

-69.62%-41.26M

Net income from continuing operations

-10.12%-69.24M

-59.27%-86.43M

-17.91%-248.5M

-17.37%-66.9M

-24.67%-64.46M

-19.65%-62.88M

-9.63%-54.27M

-60.48%-210.75M

-38.46%-57M

-62.63%-51.7M

Depreciation and amortization

32.72%1.44M

94.89%1.3M

155.69%4.09M

146.96%1.18M

202.09%1.16M

184.03%1.09M

87.08%666K

65.42%1.6M

81.37%477K

21.20%383K

Other non cash items

168.93%3.21M

578.22%7.22M

--4.63M

--1.18M

--1.19M

--1.07M

----

Change In working capital

-192.78%-5.79M

-711.99%-4.2M

59.89%13.08M

237.50%3.77M

80.91%3.58M

-12.57%6.25M

-128.75%-517K

-39.51%8.18M

-166.95%-2.74M

-33.87%1.98M

-Change in receivables

--747K

---772K

----

--0

----

-Change in inventory

---5M

---4.01M

----

--0

----

-Change in prepaid assets

-38.78%712K

69.50%2.43M

294.89%3.89M

101.41%34K

108.62%1.26M

850.32%1.16M

4,080.56%1.43M

-39.02%-2M

-301.17%-2.41M

174.26%603K

-Change in payables and accrued expense

-159.47%-2.49M

-22.24%-1.97M

-18.43%8.24M

3,728.00%3.63M

59.37%2.03M

-39.36%4.19M

-179.82%-1.61M

-27.19%10.1M

-102.46%-100K

-63.61%1.28M

-Change in other current liabilities

-73.91%233K

136.76%125K

1,169.33%952K

145.73%107K

186.27%292K

128.97%893K

-85.79%-340K

-93.10%75K

-137.56%-234K

-66.23%102K

Cash from discontinued investing activities

Operating cash flow

-19.37%-55.11M

-56.70%-71.81M

-15.54%-195.41M

-1.97%-52.56M

-23.24%-50.85M

-26.30%-46.17M

-15.25%-45.83M

-69.80%-169.13M

-61.46%-51.55M

-69.62%-41.26M

Investing cash flow

Cash flow from continuing investing activities

-39.02%21.24M

124.91%4.86M

216.55%111.9M

318.92%44.49M

309.63%52.1M

199.59%34.83M

-23.17%-19.53M

-325.58%-96.01M

-172.52%-20.32M

-302.94%-24.85M

Net PPE purchase and sale

86.01%-488K

76.75%-319K

14.58%-8.05M

14.91%-953K

-8.60%-2.23M

9.64%-3.49M

42.43%-1.37M

-46.61%-9.42M

4.52%-1.12M

14.33%-2.06M

Net investment purchase and sale

-43.30%21.73M

128.55%5.18M

238.52%119.95M

336.65%45.44M

338.35%54.34M

223.15%38.32M

-34.77%-18.16M

-276.76%-86.59M

-165.77%-19.2M

-255.63%-22.8M

Cash from discontinued investing activities

Investing cash flow

-39.02%21.24M

124.91%4.86M

216.55%111.9M

318.92%44.49M

309.63%52.1M

199.59%34.83M

-23.17%-19.53M

-325.58%-96.01M

-172.52%-20.32M

-302.94%-24.85M

Financing cash flow

Cash flow from continuing financing activities

-29.53%2M

633.80%285.48M

-81.32%55.88M

-89.00%11.11M

27.33%3.03M

-34.97%2.84M

-79.68%38.9M

4,488.37%299.16M

2,729.71%100.96M

64.11%2.38M

Net issuance payments of debt

--0

112.50%85M

--40M

--0

--40M

--0

Net common stock issuance

----

--0

----

4,323.85%288.44M

1,403.07%98M

--0

Net preferred stock issuance

--0

--199.91M

----

--0

----

Proceeds from stock option exercised by employees

-29.40%2.13M

-38.58%2M

90.23%20.41M

274.76%11.11M

27.33%3.03M

-10.97%3.02M

63.07%3.25M

--10.73M

200.41%2.96M

64.11%2.38M

Net other financing activities

27.47%-132K

67.17%-1.43M

---4.53M

--0

---182K

---4.35M

----

Cash from discontinued financing activities

Financing cash flow

-29.53%2M

633.80%285.48M

-81.32%55.88M

-89.00%11.11M

27.33%3.03M

-34.97%2.84M

-79.68%38.9M

4,488.37%299.16M

2,729.71%100.96M

64.11%2.38M

Net cash flow

Beginning cash position

268.15%298.42M

-25.70%79.88M

46.30%107.51M

-2.01%76.84M

-48.96%72.56M

-61.28%81.06M

46.30%107.51M

-40.74%73.49M

6.23%78.42M

68.33%142.16M

Current changes in cash

-275.17%-31.87M

926.10%218.53M

-181.21%-27.63M

-89.56%3.04M

106.72%4.28M

87.35%-8.49M

-119.47%-26.45M

167.34%34.02M

8,809.88%29.09M

-499.60%-63.74M

Effect of exchange rate changes

--8K

--10K

----

--0

----

End cash Position

267.34%266.56M

268.15%298.42M

-25.70%79.88M

-2.01%76.84M

-48.96%72.56M

-61.28%81.06M

46.30%107.51M

6.23%78.42M

Free cash flow

-11.97%-55.6M

-52.82%-72.13M

-13.95%-203.46M

-1.61%-53.52M

-22.54%-53.08M

-22.87%-49.65M

-11.99%-47.2M

-68.39%-178.55M

-59.12%-52.67M

-62.08%-43.32M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019	(Q2)Jun 30, 2019	(Q1)Mar 31, 2019	(FY)Dec 31, 2018	(Q4)Dec 31, 2018	(Q3)Sep 30, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-19.37%-55.11M	-56.70%-71.81M	-15.54%-195.41M	-1.97%-52.56M	-23.24%-50.85M	-26.30%-46.17M	-15.25%-45.83M	-69.80%-169.13M	-61.46%-51.55M	-69.62%-41.26M
Net income from continuing operations	-10.12%-69.24M	-59.27%-86.43M	-17.91%-248.5M	-17.37%-66.9M	-24.67%-64.46M	-19.65%-62.88M	-9.63%-54.27M	-60.48%-210.75M	-38.46%-57M	-62.63%-51.7M
Depreciation and amortization	32.72%1.44M	94.89%1.3M	155.69%4.09M	146.96%1.18M	202.09%1.16M	184.03%1.09M	87.08%666K	65.42%1.6M	81.37%477K	21.20%383K
Other non cash items	168.93%3.21M	578.22%7.22M	--4.63M	--1.18M	--1.19M	--1.19M	--1.07M	----	----	----
Change In working capital	-192.78%-5.79M	-711.99%-4.2M	59.89%13.08M	237.50%3.77M	80.91%3.58M	-12.57%6.25M	-128.75%-517K	-39.51%8.18M	-166.95%-2.74M	-33.87%1.98M
-Change in receivables	--747K	---772K	----	----	----	--0	--0	----	----	----
-Change in inventory	---5M	---4.01M	----	----	----	--0	--0	----	----	----
-Change in prepaid assets	-38.78%712K	69.50%2.43M	294.89%3.89M	101.41%34K	108.62%1.26M	850.32%1.16M	4,080.56%1.43M	-39.02%-2M	-301.17%-2.41M	174.26%603K
-Change in payables and accrued expense	-159.47%-2.49M	-22.24%-1.97M	-18.43%8.24M	3,728.00%3.63M	59.37%2.03M	-39.36%4.19M	-179.82%-1.61M	-27.19%10.1M	-102.46%-100K	-63.61%1.28M
-Change in other current liabilities	-73.91%233K	136.76%125K	1,169.33%952K	145.73%107K	186.27%292K	128.97%893K	-85.79%-340K	-93.10%75K	-137.56%-234K	-66.23%102K
Cash from discontinued investing activities
Operating cash flow	-19.37%-55.11M	-56.70%-71.81M	-15.54%-195.41M	-1.97%-52.56M	-23.24%-50.85M	-26.30%-46.17M	-15.25%-45.83M	-69.80%-169.13M	-61.46%-51.55M	-69.62%-41.26M
Investing cash flow
Cash flow from continuing investing activities	-39.02%21.24M	124.91%4.86M	216.55%111.9M	318.92%44.49M	309.63%52.1M	199.59%34.83M	-23.17%-19.53M	-325.58%-96.01M	-172.52%-20.32M	-302.94%-24.85M
Net PPE purchase and sale	86.01%-488K	76.75%-319K	14.58%-8.05M	14.91%-953K	-8.60%-2.23M	9.64%-3.49M	42.43%-1.37M	-46.61%-9.42M	4.52%-1.12M	14.33%-2.06M
Net investment purchase and sale	-43.30%21.73M	128.55%5.18M	238.52%119.95M	336.65%45.44M	338.35%54.34M	223.15%38.32M	-34.77%-18.16M	-276.76%-86.59M	-165.77%-19.2M	-255.63%-22.8M
Cash from discontinued investing activities
Investing cash flow	-39.02%21.24M	124.91%4.86M	216.55%111.9M	318.92%44.49M	309.63%52.1M	199.59%34.83M	-23.17%-19.53M	-325.58%-96.01M	-172.52%-20.32M	-302.94%-24.85M
Financing cash flow
Cash flow from continuing financing activities	-29.53%2M	633.80%285.48M	-81.32%55.88M	-89.00%11.11M	27.33%3.03M	-34.97%2.84M	-79.68%38.9M	4,488.37%299.16M	2,729.71%100.96M	64.11%2.38M
Net issuance payments of debt	--0	112.50%85M	--40M	--0	--0	--0	--40M	--0	--0	--0
Net common stock issuance	----	----	--0	--0	----	----	----	4,323.85%288.44M	1,403.07%98M	--0
Net preferred stock issuance	--0	--199.91M	----	----	----	--0	--0	----	----	----
Proceeds from stock option exercised by employees	-29.40%2.13M	-38.58%2M	90.23%20.41M	274.76%11.11M	27.33%3.03M	-10.97%3.02M	63.07%3.25M	--10.73M	200.41%2.96M	64.11%2.38M
Net other financing activities	27.47%-132K	67.17%-1.43M	---4.53M	--0	--0	---182K	---4.35M	----	----	----
Cash from discontinued financing activities
Financing cash flow	-29.53%2M	633.80%285.48M	-81.32%55.88M	-89.00%11.11M	27.33%3.03M	-34.97%2.84M	-79.68%38.9M	4,488.37%299.16M	2,729.71%100.96M	64.11%2.38M
Net cash flow
Beginning cash position	268.15%298.42M	-25.70%79.88M	46.30%107.51M	-2.01%76.84M	-48.96%72.56M	-61.28%81.06M	46.30%107.51M	-40.74%73.49M	6.23%78.42M	68.33%142.16M
Current changes in cash	-275.17%-31.87M	926.10%218.53M	-181.21%-27.63M	-89.56%3.04M	106.72%4.28M	87.35%-8.49M	-119.47%-26.45M	167.34%34.02M	8,809.88%29.09M	-499.60%-63.74M
Effect of exchange rate changes	--8K	--10K	----	----	----	--0	--0	----	----	----
End cash Position	267.34%266.56M	268.15%298.42M	-25.70%79.88M	-25.70%79.88M	-2.01%76.84M	-48.96%72.56M	-61.28%81.06M	46.30%107.51M	46.30%107.51M	6.23%78.42M
Free cash flow	-11.97%-55.6M	-52.82%-72.13M	-13.95%-203.46M	-1.61%-53.52M	-22.54%-53.08M	-22.87%-49.65M	-11.99%-47.2M	-68.39%-178.55M	-59.12%-52.67M	-62.08%-43.32M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data